Navigation Links
2 views are better than 1 in 3-D breast screening
Date:4/18/2013

One view 3D breast screening (tomosynthesis) means less radiation dose and about five seconds less compression, but a study from Yale University, New Haven, CT, found that obtaining both views is necessary to help ensure that a cancer won't be missed.

There are practices in Europe that have reported performing only a single view, specifically the mediolateral oblique (MLO) view, said Dr. Noa Beck, the lead author of the study. Two views are standard in the U.S. for 3D breast screening; "we wanted to see if one view would be sufficient," she said. Seven breast imagers reviewed 164 cancers visualized with tomosynthesis and noted on what views the cancers could be seen. The study found that 56% of cancers were equally well seen on both the MLO view and the craniocaudal (CC) view; 34% of the cancers were either better or only seen on the CC view, said Dr. Beck. "The CC view achieves better compression, and this likely explains the reason the CC view showed lesions more clearly. In a few cases, lesions were only seen on the MLO view because of where the cancers were located in the breast," she said.

The study results emphasize that "obtaining both views is necessary to ensure that a cancer will be optimally visualized," said Dr. Beck.

Dr. Beck will present her study at the ARRS annual meeting on April 19 in Washington, DC.


'/>"/>

Contact: Samantha Schmidt
sschmidt@arrs.org
703-858-4316
American Roentgen Ray Society
Source:Eurekalert

Page: 1

Related medicine news :

1. Cellulite Factor: Review Examining Dr. Charles Livingston’s Immediate Download Program Released By CelluliteFactorReviews.org
2. Jacksonsville FL Hearing Aid Reviews Made Available Online to Share the Stories of Local Residents that have Overcome Hearing Loss
3. Medical Marketing Firm MCPR Introduces Dermatology Expert for Media Interviews
4. How To Get Rid Of Stress
5. How “Prime Stress” Helps People Handle Stress – Health Reviews
6. Medical Marketing Firm MCPR Introduces Joint Replacement Expert for Media Interviews
7. Dr Jason Diamond Reviews ASPS Study of Most Popular Cosmetic Surgery Procedures in America
8. Medical Marketing Firm MCPR Introduces Spinal Cord Injury Expert for Media Interviews
9. Last Chance to Register for Career Confidential Complimentary Live Webinar that will Teach Job Seekers how to Create a Resume that gets Interviews
10. Neuropathy Treatment
11. How “The Neuropathy Solution” Helps People Treat Neuropathy Quickly – Health Reviews
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/22/2017)... ... 22, 2017 , ... Silicon Valley startup Enke Life has ... Their electric toothbrushes aggressively attack oral bacteria by reducing dental plaque and other ... edge Enke technology with a premium timeless design, they want to redefine the ...
(Date:9/22/2017)... ... September 22, 2017 , ... Egg ... life. Although frozen embryos have a slight statistical advantage for live births, frozen ... a wonderful opportunity for women undergoing medical treatment or who are concerned about ...
(Date:9/21/2017)... ... September 21, 2017 , ... Process Capability Indices for ... 3:00 p.m. ET, http://www.fdanews.com/processcapabilityindices      , Quality in device ... of The Quality System Regulation (§820.250), and Devicemakers find themselves staring at a ...
(Date:9/21/2017)... ... September 21, 2017 , ... ... of a new member survey conducted by the International Society of Hair ... from 2014 to 2016 rose 60 percent, with 635,189 procedures performed in 2016. ...
(Date:9/21/2017)... ... 21, 2017 , ... Innovatum will demonstrate capabilities of fully ... Conference 2017 in Chicago, IL on October 17-19, 2017. This unique development addresses ... patient safety. , Microscan , a global technology leader in barcoding, ...
Breaking Medicine News(10 mins):
(Date:9/6/2017)... , Sept. 6, 2017 Eli Lilly and ... will present new data for galcanezumab and lasmiditan, two ... the International Headache Society (IHC) taking place Sept. 7-10 ... Lilly will highlight new, long-term data from an open-label ... of galcanezumab (120 mg and 240 mg) for the ...
(Date:9/5/2017)... , Sept. 5, 2017 Oramed Pharmaceuticals Inc. ... ), a clinical-stage pharmaceutical company focused on the development ... has successfully concluded its meeting with the U.S. Food ... oral insulin formulation. ... the regulatory pathway for submission of ORMD-0801, would be ...
(Date:8/29/2017)... , Aug. 29, 2017 ivWatch, LLC, the leading provider ... infiltrations, announced it has been awarded an Innovative Technology contract from ... the country. ... device to aid in the early detection of peripheral IV infiltration ... The Innovative Technology contract ...
Breaking Medicine Technology: